Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 15;12(6):780-785.
doi: 10.4239/wjd.v12.i6.780.

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare

Ines Bilic Curcic  1 , Maja Cigrovski Berkovic  2 , Tomislav Kizivat  3 , Silvija Canecki Varzic  1 , Robert Smolic  4 , Martina Smolic  5
Affiliations
Review

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare

Ines Bilic Curcic et al. World J Diabetes. .

Abstract

The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for telemedicine implementation right at the beginning of the COVID-19 pandemic. The results of these remote interventions are reassuring in terms of glycemic management and hemoglobin A1c reductions. However, data on long-term outcomes and cost reductions are missing as well as proper technical infrastructure and government health policy support.

Keywords: COVID-19; Diabetes management; Diabetes type 1; Telemedicine.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: There is no conflict of interest associated with the senior author or other coauthors.

Figures

Figure 1
Figure 1
Essential requirements for successful implementation of telemedicine in the management of type 1 diabetes. CGM: Continuous glucose monitoring; FGM: Flash glucose monitoring.
See this image and copyright information in PMC

References

    1. Worldometer COVID-19 coronavirus pandemic 2021. [cited 1 January 2021]. Available from: www.worldometers.info/coronavirus/
    1. International Diabetes Federation. IDF Diabetes Atlas, 8th ed. Brussels, Belgium: 2019. [cited May 4, 2020]. Available from: www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabe... .
    1. Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol . 2020;8:823–833. - PMC - PubMed
    1. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, MacKenna B, Tomlinson L, Douglas IJ, Rentsch CT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L, Goldacre B. Factors associated with COVID-19-related death using OpenSAFELY. Nature . 2020;584:430–436. - PMC - PubMed
    1. Wake DJ, Gibb FW, Kar P, Kennon B, Klonoff DC, Rayman G, Rutter MK, Sainsbury C, Semple RK. ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation. Eur J Endocrinol . 2020;183:G67–G77. - PMC - PubMed